The estimated Net Worth of Jeffrey N Simmons is at least $21.4 Million dollars as of 12 August 2024. Mr. Simmons owns over 100,000 units of Elanco Animal Health Inc stock worth over $2,099,600 and over the last 15 years he sold ELAN stock worth over $3,494,165. In addition, he makes $15,801,800 as President, Chief Executive Officer, and Director at Elanco Animal Health Inc.
Jeffrey has made over 22 trades of the Elanco Animal Health Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he bought 100,000 units of ELAN stock worth $1,301,000 on 12 August 2024.
The largest trade he's ever made was buying 100,000 units of Elanco Animal Health Inc stock on 12 August 2024 worth over $1,301,000. On average, Jeffrey trades about 6,297 units every 65 days since 2010. As of 12 August 2024 he still owns at least 145,000 units of Elanco Animal Health Inc stock.
You can see the complete history of Mr. Simmons stock trades at the bottom of the page.
Jeffrey N. Simmons is the President, Chief Executive Officer and Director of the Company. Mr. Simmons as served as Elanco’s President and Chief Executive Officer and as a member of the Board since July 2018. Mr. Simmons served as the President of the Elanco Animal Health division of Lilly and Senior Vice President of Lilly from 2008 until September 2018. Prior to 2008, Mr. Simmons held various leadership roles for Elanco, including District Sales Manager, International Marketing Manager, Country Director for Brazil, Area Director for Western Europe and Executive Director for U.S. and Global Research & Development. Mr. Simmons’ experience described above, including his knowledge of Elanco and the animal health industry and his business and management experience, provides him with the qualifications and skills to serve as a director on Elanco’s Board.
As the President, Chief Executive Officer, and Director of Elanco Animal Health Inc, the total compensation of Jeffrey Simmons at Elanco Animal Health Inc is $15,801,800. There are no executives at Elanco Animal Health Inc getting paid more.
Jeffrey Simmons is 52, he's been the President, Chief Executive Officer, and Director of Elanco Animal Health Inc since 2018. There are 15 older and 11 younger executives at Elanco Animal Health Inc. The oldest executive at Elanco Animal Health Inc is R. David Hoover, 74, who is the Independent Chairman of the Board.
Jeffrey's mailing address filed with the SEC is C/O ELANCO ANIMAL HEALTH INCORPORATED, 2500 INNOVATION WAY, GREENFIELD, IN, 46140.
Over the last 6 years, insiders at Elanco Animal Health Inc have traded over $1,626,280,000 worth of Elanco Animal Health Inc stock and bought 657,104 units worth $14,225,149 . The most active insiders traders include Aktiengesellschaft Bayer Wo..., Scott D.Sachem Head Capital..., and R David Hoover. On average, Elanco Animal Health Inc executives and independent directors trade stock every 38 days with the average trade being worth of $14,011,833. The most recent stock trade was executed by Michael J Harrington on 22 August 2024, trading 3,500 units of ELAN stock currently worth $51,975.
elanco is a global animal health company. our vision: food and companionship enriching life. elanco fulfills this vision through three primary pursuits: - helping deliver a safe, more affordable, more abundant food supply by improving the health and performance of animals - helping pets live longer, healthier, higher-quality lives - improving food safety elanco employees are empowered to preserve elanco’s common culture of humility, discipline and involvement. we have a responsibility to connect and contribute to our cause, to be passionate about delivering solutions and value to our customers, and to embrace opportunities for personal and professional growth and development. through innovative products, quality systems and a shared vision, elanco strives daily to enhance animal health—and enrich the lives of people worldwide.
Elanco Animal Health Inc executives and other stock owners filed with the SEC include: